We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOA.WS
1051
CALL
DELISTED
Finance of America Companies Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
FOA.WS
$3.43M 0.02%
+450,000
New +$613K
RTL
1052
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$3.43M 0.02%
+405,006
New +$3.78M
IACC
1053
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
$3.43M 0.02%
+350,000
New +$3.46M
HGV icon
1054
Hilton Grand Vacations
HGV
$3.98B
$3.43M 0.02%
+82,934
New +$3.6M
LDTC
1055
DELISTED
LeddarTech
LDTC
$3.43M 0.02%
707,436
CANO.WS
1056
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$3.43M 0.02%
+283,332
New +$1.28M
MTB icon
1057
M&T Bank
MTB
$36B
$3.42M 0.02%
23,547
+1,521
+7% +$238K
BMRN icon
1058
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.42M 0.02%
+40,951
New +$3.25M
LDOS icon
1059
Leidos
LDOS
$14.5B
$3.41M 0.02%
+33,768
New +$3.47M
CNC icon
1060
Centene
CNC
$31.6B
$3.4M 0.02%
46,652
-691,489
-94% -$47.4M
ATHN.WS
1061
CALL
DELISTED
Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
ATHN.WS
$3.4M 0.02%
+350,699
New +$265K
RARE icon
1062
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.39M 0.02%
+35,529
New +$3.7M
EUSG
1063
DELISTED
European Sustainable Growth Acquisition Corp. Class A Ordinary Shares
EUSG
$3.39M 0.02%
349,990
JCIC
1064
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
$3.38M 0.02%
349,990
BCH icon
1065
Banco de Chile
BCH
$20.9B
$3.37M 0.02%
+170,410
New +$3.66M
SCOAW
1066
CALL
DELISTED
ScION Tech Growth I Warrant
SCOAW
$3.35M 0.02%
342,561
+9,233
+3% +$8.29K
CNX icon
1067
CNX Resources
CNX
$4.77B
$3.33M 0.02%
+244,188
New +$3.42M
XOP icon
1068
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.47B
$3.33M 0.02%
+34,470
New +$3.01M
LNC icon
1069
Lincoln National
LNC
$7.88B
$3.33M 0.02%
53,031
-186,521
-78% -$12.3M
GEN icon
1070
Gen Digital
GEN
$16.1B
$3.32M 0.02%
122,103
-336,483
-73% -$8.38M
BY icon
1071
Byline Bancorp
BY
$1.76B
$3.32M 0.02%
+146,791
New +$3.29M
DESP
1072
DELISTED
Despegar.com
DESP
$3.32M 0.02%
+251,508
New +$3.39M
KIIIW
1073
CALL
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$3.32M 0.02%
+344,570
New +$228K
XYL icon
1074
Xylem
XYL
$28.6B
$3.31M 0.02%
27,598
+8,129
+42% +$928K
CTAC.WS
1075
CALL
DELISTED
Cerberus Telecom Acquisition Corp. Warrants included as part of the Units, each whole warrant exerci
CTAC.WS
$3.31M 0.02%
333,327

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.